Molecular Evidence for a Dimensional Basis of Depression
收藏官方服务：
资源简介：
Molecular Evidence for a Dimensional Basis of Depression
应用场景：
创建时间：
2016-07-03
相关数据集
Mechanistic differences in neuropathic pain modalities revealed by correlating behavior with global expression profiling [microarray]
Chronic neuropathic pain is a major morbidity of neural injury, yet its mechanisms are incompletely understood. Hypersensitivity to previously non-noxious stimuli (allodynia) is a common symptom. Here
NIAID Data Ecosystem110
Table_1_Metabolome and transcriptome integration reveals cerebral cortical metabolic profiles in rats with subarachnoid hemorrhage.XLSX
Subarachnoid hemorrhage (SAH) is a severe subtype of hemorrhagic stroke. The molecular mechanisms of its secondary brain damage remain obscure. To investigate the alterations in gene and metabolite le
NIAID Data Ecosystem00
Table2_Plasma alpha-trypsin inhibitor heavy chain 4 as an age-specific biomarker in the diagnosis and treatment of major depressive disorder.xlsx
BackgroundThe diagnosis of major depressive disorder (MDD) mainly depends on subjective clinical symptoms, without an acceptable objective biomarker for the clinical application of MDD. Inter-alpha-tr
NIAID Data Ecosystem00
The nasal microbiome and metabolites are altered in depression patients
Depressive disorder is a heterogeneous neuropsychiatric disorder. It affects millions of people worldwide. The exact causes of depressive behavior remain unclear and are believed to implicate both gen
NIAID Data Ecosystem40
Broad rim lesions are a novel pathological / morphological and imaging biomarker for rapid disease progression in Multiple Sclerosis (part 2)
Current Multiple Sclerosis (MS) treatments reduce relapse activity but have limited impact on disease progression. Clinical trials targeting progression often fail due to insufficient understanding of
NIAID Data Ecosystem00
